Hypertension in Breast Cancer Patients Receiving Bevacizumab
Status:
Terminated
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
This research study will look at the effect of an anti-angiogenesis medication called
Bevacizumab on blood vessels. Anti-angiogenesis medicines fight cancer by cutting off a
tumor's blood supply, starving the tumor of nutrients and oxygen. Previous studies have shown
these types of drugs can cause hypertension. The purpose of this study is to help researchers
better understand why these drugs cause hypertension. This information will assist
researchers in learning how to control this side effect.